Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 191.29M P/E - EPS this Y -8.10% Ern Qtrly Grth -
Income -49.12M Forward P/E -3.24 EPS next Y -11.20% 50D Avg Chg -45.00%
Sales 2.76M PEG - EPS past 5Y - 200D Avg Chg -54.00%
Dividend N/A Price/Book 1.70 EPS next 5Y - 52W High Chg -77.00%
Recommedations 1.70 Quick Ratio 7.82 Shares Outstanding 35.79M 52W Low Chg 3.00%
Insider Own 32.17% ROA -33.75% Shares Float 19.46M Beta 0.14
Inst Own 41.98% ROE -81.48% Shares Shorted/Prior 833.31K/876.40K Price 5.35
Gross Margin 93.26% Profit Margin - Avg. Volume 79,104 Target Price 16.33
Oper. Margin -4,763.74% Earnings Date - Volume 21,127 Change -2.73%
About Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Orchestra BioMed Holdings, Inc. News
04/30/24 Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
04/30/24 Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
03/29/24 Orchestra BioMed Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
03/27/24 Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
03/26/24 Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
03/13/24 Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
03/07/24 Orchestra BioMed to Participate in Upcoming Investor Conferences
03/06/24 Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients
02/26/24 Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years
02/16/24 Why Orchestra BioMed (OBIO) Might Surprise This Earnings Season
07:30 AM Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients
01/03/24 Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has caught the attention of hedge funds investors who hold a sizeable 28% stake
11/13/23 Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update
11/09/23 Orchestra BioMed to Present at Upcoming Investor Conferences
10/30/23 Billionaire Marc Lasry’s Top 10 Stock Picks
09/19/23 Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients
09/06/23 Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors
08/10/23 Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Update
07:30 AM Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis
07/27/23 Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) stock most popular amongst retail investors who own 36%, while hedge funds hold 28%
OBIO Chatroom

User Image JonhanDAO Posted - 5 days ago

$OBIO Market Cap: 198615088 Forward P/E Ratio: -3.1179776 Dividend Yield: N/A Earnings Per Share (EPS): -1.48 Price/Book Ratio: 2.9179811 Debt to Equity Ratio: 2.479 Get more info: https://www.openweb.com/share/2RAHIMDxYbCVOhuve5KHEj3SJst

User Image HypnoTrader Posted - 04/30/24

$OBIO Orchestra BioMed. What an obscure reference. I assumed they were in bankruptcy, long gone and delisted, but no, here they are. Still filing patents, traveling to conferences, having drinks. Good for them.

User Image Stock_Titan Posted - 04/30/24

$OBIO Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents https://www.stocktitan.net/news/OBIO/orchestra-bio-med-announces-avim-therapy-global-intellectual-nnxms5t2ar2y.html

User Image Stock_Titan Posted - 04/30/24

$OBIO Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 https://www.stocktitan.net/news/OBIO/orchestra-bio-med-to-host-in-person-r-d-day-in-new-york-on-avim-8v9v3tma7b7f.html

User Image MonopolyMoneyMillionare Posted - 1 month ago

$MOTS this and $OBIO are easily lawsuits waiting to happen

User Image ThebookofEli Posted - 1 month ago

$OBIO starter position

User Image JimmyYah Posted - 03/27/24

$IBIO Why is there so much volume for $OBIO shares right now?.. is it going to blast off tmrw?!

User Image Stock_Titan Posted - 03/27/24

$OBIO Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update https://www.stocktitan.net/news/OBIO/orchestra-bio-med-reports-full-year-2023-financial-results-and-jid3m15wxdf8.html

User Image briefingcom Posted - 03/13/24

$OBIO: Orchestra BioMed demonstrates strength of cardiovascular pipeline with Virtue SAB and AVIM Therapy presentations at CRT 2024 Annual Meeting https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240313080557OBIO&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image Stock_Titan Posted - 03/13/24

$OBIO Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting https://www.stocktitan.net/news/OBIO/orchestra-bio-med-demonstrates-strength-of-cardiovascular-pipeline-h3o1e7hx9d4u.html

User Image Stock_Titan Posted - 2 months ago

$OBIO Orchestra BioMed to Participate in Upcoming Investor Conferences https://www.stocktitan.net/news/OBIO/orchestra-bio-med-to-participate-in-upcoming-investor-81sn7yphylwu.html

User Image Stock_Titan Posted - 2 months ago

$OBIO Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients https://www.stocktitan.net/news/OBIO/orchestra-bio-med-announces-presentation-of-results-from-clinical-p2inpvwl82lv.html

User Image Ninja_Tradez Posted - 2 months ago

Don's forget to check Calendar: https://www.tradershub.ninja/calendar $TRDA $CRT $OBIO $KRNL Never Miss any alert 🚨Check Discord Link 🔗 on bio

User Image Mergy Posted - 02/27/24

$OBIO https://finnhub.io/api/news?id=4f86421cdac3d2a64fdb6c96000b4d7e8cc9a5262d0b948f1dd1c82ff2a7126e

User Image CanadaPride Posted - 02/26/24

$OBIO how much cash they have on hand? Anyone. Is it worth 230M market cap with less thn 1 M quatery revenue

User Image briefingcom Posted - 02/26/24

$OBIO: Orchestra BioMed announces the presentation of new data demonstrating the long-term effect of atrioventricular interval modulation therapy on generating clinically-meaningful reductions in 24-hour ambulatory systolic blood pressure in pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240226080808OBIO&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image Stock_Titan Posted - 02/26/24

$OBIO Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years https://www.stocktitan.net/news/OBIO/orchestra-bio-med-presents-new-data-showing-sustained-clinically-e9ey0iph4wpy.html

User Image Mergy Posted - 02/22/24

$OBIO https://finance.yahoo.com/news/why-orchestra-biomed-obio-might-141300438.html Orchestra BioMed (OBIO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

User Image brodobagginz Posted - 3 months ago

$OBIO did this get halted ?

User Image StockAutomatePro Posted - 01/22/24

$OBIO The stock looks poised for growth based on the chart. We alerted the BUY signal at $7.5 and we were able to close this one with profit at $9.35 🔏

User Image Fullratio Posted - 01/22/24

$OBIO EPS has soared by 179% YoY: https://fullratio.com/stocks/nasdaq-obio/orchestra-biomed-holdings

User Image WinifredCummings Posted - 01/22/24

$DWACU $OBIO $ASPS ACCOUNT CHALLENGE UPDATE: Starting Balance: $3,700 Current Balance: $54,873 Goal: $100K by end of Jan. Watch out for our next alert!.~~<:🤷‍♀️👉 stocks-great-winning-trades.profitablestocks.vip/

User Image Grimy4828 Posted - 01/22/24

$OBIO THANKS, OBIO

User Image VenitaSaavedra Posted - 01/21/24

$CCTG $SEZL $DWACU $OBIO Started trading over 4 months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts.. Highly recommended! It's free joining.,,,.;🌴👉 stocks-great-winning-trades.profitablestocks.vip/

User Image StockAutomatePro Posted - 01/21/24

$OBIO Good news for investors chart analysis shows upward momentum. We alerted the BUY signal at $7.5 and we were able to close this one with profit at $8.72 💖

User Image BrendaOakley Posted - 01/20/24

$SEZL $DJTWW $OBIO ACCOUNT CHALLENGE UPDATE: Starting Balance: $3,700 Current Balance: $54,873 Goal: $100K by end of Jan. Watch out for our next alert!.,.,;💦👉 stocks-great-winning-trades.profitablestocks.vip/

User Image UltraAlgo Posted - 01/19/24

$OBIO 28.68% up since our buy rating. Learn more at UltraAlgo.com

User Image brodobagginz Posted - 01/10/24

$OBIO this makes me want to rip my hair out lol

User Image Stock_Titan Posted - 3 months ago

$OBIO Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients https://www.stocktitan.net/news/OBIO/orchestra-bio-med-announces-initiation-of-backbeat-pivotal-study-of-pd27z9n1ixd6.html

User Image brodobagginz Posted - 4 months ago

$OBIO what a fucking joke ugh

Analyst Ratings
Chardan Capital Buy Mar 28, 24
Jefferies Buy Jan 19, 24
Chardan Capital Buy Aug 11, 23
Chardan Capital Buy Aug 9, 23
Chardan Capital Buy May 15, 23
Piper Sandler Overweight Feb 24, 23
Chardan Capital Buy Feb 7, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ROSE ERIC A MD Director Director May 17 Option 1.08 2,325 2,511 2,325 05/19/23
Fain Eric S Director Director May 10 Option 1.08 2,906 3,138 29,767 05/12/23
Medtronic plc 10% Owner 10% Owner Jan 30 Buy 9.281 6,835 63,436 4,999,423 02/01/23
WONG RODERICK Chief Executive Offi.. Chief Executive Officer Jan 24 Buy 10.00 1,808,512 18,085,120 2,808,512 01/26/23
WONG RODERICK Chief Executive Offi.. Chief Executive Officer Jul 22 Buy 10.01 1,000,000 10,010,000 1,000,000 07/25/22